AU2023269038A1 - Solid forms of a compound for modulating cot - Google Patents

Solid forms of a compound for modulating cot Download PDF

Info

Publication number
AU2023269038A1
AU2023269038A1 AU2023269038A AU2023269038A AU2023269038A1 AU 2023269038 A1 AU2023269038 A1 AU 2023269038A1 AU 2023269038 A AU2023269038 A AU 2023269038A AU 2023269038 A AU2023269038 A AU 2023269038A AU 2023269038 A1 AU2023269038 A1 AU 2023269038A1
Authority
AU
Australia
Prior art keywords
formula
degrees
reflections
solid form
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023269038A
Other languages
English (en)
Inventor
Ernest A. Carra
Lina Chan
Roland D. Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AU2023269038A1 publication Critical patent/AU2023269038A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2023269038A 2022-05-12 2023-05-10 Solid forms of a compound for modulating cot Pending AU2023269038A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263341289P 2022-05-12 2022-05-12
US63/341,289 2022-05-12
PCT/US2023/021659 WO2023220123A1 (en) 2022-05-12 2023-05-10 Solid forms of a compound for modulating cot

Publications (1)

Publication Number Publication Date
AU2023269038A1 true AU2023269038A1 (en) 2024-11-28

Family

ID=86710687

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023269038A Pending AU2023269038A1 (en) 2022-05-12 2023-05-10 Solid forms of a compound for modulating cot

Country Status (9)

Country Link
US (1) US20240174702A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522268A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025515671A (cg-RX-API-DMAC7.html)
KR (1) KR20250008904A (cg-RX-API-DMAC7.html)
CN (1) CN119137131A (cg-RX-API-DMAC7.html)
AU (1) AU2023269038A1 (cg-RX-API-DMAC7.html)
CA (1) CA3252705A1 (cg-RX-API-DMAC7.html)
TW (1) TWI863271B (cg-RX-API-DMAC7.html)
WO (1) WO2023220123A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI915558B (zh) 2019-06-14 2026-02-21 美商基利科學股份有限公司 Cot 調節劑及其使用方法
CA3175541A1 (en) 2020-03-30 2021-10-07 Gilead Sciences, Inc. Solid forms of (s)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1h-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
EP4126862B1 (en) 2020-04-02 2025-05-21 Gilead Sciences, Inc. Process for preparing a cot inhibitor compound
TW202523303A (zh) * 2023-12-11 2025-06-16 美商基利科學股份有限公司 用於治療發炎性腸道疾病之化合物及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI915558B (zh) 2019-06-14 2026-02-21 美商基利科學股份有限公司 Cot 調節劑及其使用方法

Also Published As

Publication number Publication date
JP2025515671A (ja) 2025-05-20
EP4522268A1 (en) 2025-03-19
WO2023220123A1 (en) 2023-11-16
TWI863271B (zh) 2024-11-21
CN119137131A (zh) 2024-12-13
TW202400161A (zh) 2024-01-01
KR20250008904A (ko) 2025-01-16
US20240174702A1 (en) 2024-05-30
CA3252705A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
US20240174702A1 (en) Solid forms of a compound for modulating cot
EP3962602B1 (en) Itaconic acid derivatives and uses thereof in treating an inflammatory disease or a disease associated with an undesirable immune response
US12459908B2 (en) Alpha, beta unsaturated methacrylic esters with anti-inflammatory properties
JP6901479B2 (ja) Cxcr2の阻害剤
EP3983064B1 (en) Cot modulators and methods of use thereof
US20240010606A1 (en) Fumarate derivatives and their medical use
US20230381132A1 (en) Novel compounds
US10633365B2 (en) Synthesis of indazoles
US20170210756A1 (en) Synthesis of an antiviral compound
WO2022221642A1 (en) Thienopyrrole compounds
US20240360067A1 (en) Derivatives of itaconic acid and their use as anti-inflammatory agents
WO2022140326A1 (en) Substituted indole compounds
US20260138973A1 (en) Substituted pyridines for use in treating or preventing inflammatory diseases or diseases associated with an undesirable immune response
JP2015529254A (ja) 喘息における気道の過敏症及び炎症を制御するための新規なgabaaアゴニスト及び使用方法
HK40119474A (en) Solid forms of a compound for modulating cot
WO2022217063A1 (en) (s)-3-amino-4-(difluoromethylene)cyclohexene and cyclohexane carboxylic acid and uses thereof as selective inactivators of human ornithine aminotransferase (hoat)
WO2025191141A1 (en) Methods of preparing carbamate derivatives
EP4398989A1 (en) Thienopyrrole compounds
NZ746469B2 (en) Synthesis of indazoles